News Headlines Article

Week Ahead: Senate committee to grill Big Pharma on drug prices
Modern Healthcare

Feb. 25: Wall Street watchers predict a dip in revenue when Dallas-based Tenet Healthcare Corp. releases its fourth-quarter earnings. Zacks Investment Research anticipates the for-profit hospital chain’s revenue to be down 9.8% from the same period in 2017. The company is also expected to report that it paid off close to $30 million of debt.

Feb. 26: Who’s bringing the popcorn? Executives from seven Big Pharma companies will line up for questioning from the Senate Finance Committee in a hearing dubbed “Drug Pricing in America: A Prescription for Change, Part II.” Committee Chairman Chuck Grassley (R-Iowa) started the inquiry into drug prices last month. Grassley has supported efforts to crack down on manufacturer pay-to-delay tactics that stall generics from entering the market, as well as legislation to expedite generic drugs and biosimilars to market, which faces opposition from drug companies.